Effect of long-term therapy with AT1angiotensin II receptor blockers in combination with aldosterone receptor inhibitor on ischemic myocardial remodelling and chronic heart failure

Effect of long-term therapy with AT1angiotensin II receptor blockers in combination with aldosterone receptor inhibitor on ischemic myocardial remodelling and chronic heart failure

The article presents the results of a 6-month long-term therapy with angiotensin II receptor blocker Valsacor and aldosterone receptor blocker Spironolactone in patients with chronic heart failure (CHF) against a background of ischemic and/or post-infarction left ventricular remodelling. The results...

Full description

Bibliographic Details
Main Authors: AT Teplyakov, EV Grakova, AV Andrianova, EY Pushnikova, NV Protopopova, RS Karpov
Format: Article
Language:Russian
Published: Remedium Group LLC 2014-12-01
Series:Медицинский совет
Subjects:
блокатор рецепторов ангиотензина
блокатор рецепторов альдостерона
ремоделирование лж
сердечная недостаточность
дисфункция миокарда
angiotensin receptor blocker
aldosterone receptor blocker
lv remodeling
heart failure
myocardial dysfunction
Online Access:https://www.med-sovet.pro/jour/article/view/692

Similar Items

Similar Items